SG10201804034QA - Methods for treating hypotension - Google Patents

Methods for treating hypotension

Info

Publication number
SG10201804034QA
SG10201804034QA SG10201804034QA SG10201804034QA SG10201804034QA SG 10201804034Q A SG10201804034Q A SG 10201804034QA SG 10201804034Q A SG10201804034Q A SG 10201804034QA SG 10201804034Q A SG10201804034Q A SG 10201804034QA SG 10201804034Q A SG10201804034Q A SG 10201804034QA
Authority
SG
Singapore
Prior art keywords
methods
hypotension
treating hypotension
treating
angiotensin
Prior art date
Application number
SG10201804034QA
Other languages
English (en)
Inventor
George Tidmarsh
Lakhmir Chawla
Original Assignee
La Jolla Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Jolla Pharma Co filed Critical La Jolla Pharma Co
Publication of SG10201804034QA publication Critical patent/SG10201804034QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SG10201804034QA 2014-07-08 2015-07-08 Methods for treating hypotension SG10201804034QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462022054P 2014-07-08 2014-07-08

Publications (1)

Publication Number Publication Date
SG10201804034QA true SG10201804034QA (en) 2018-07-30

Family

ID=55064810

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201804034QA SG10201804034QA (en) 2014-07-08 2015-07-08 Methods for treating hypotension
SG11201610897VA SG11201610897VA (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201610897VA SG11201610897VA (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Country Status (14)

Country Link
US (3) US20160074465A1 (https=)
EP (2) EP3007722A4 (https=)
JP (2) JP2017519799A (https=)
KR (1) KR20170026486A (https=)
CN (1) CN106794224A (https=)
AU (2) AU2015287955A1 (https=)
BR (1) BR112017000303A2 (https=)
CA (1) CA2954016A1 (https=)
EA (2) EA202091873A3 (https=)
IL (1) IL249936A0 (https=)
MX (1) MX2017000306A (https=)
SG (2) SG10201804034QA (https=)
TW (3) TWI754225B (https=)
WO (1) WO2016007589A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
PL2986308T3 (pl) 2013-12-18 2020-05-18 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensyna ii w połączeniu do leczenia niedociśnienia
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
PL3400000T3 (pl) 2016-01-07 2024-04-22 La Jolla Pharma, Llc Sposoby podawania angiotensyny ii
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2019118874A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
WO2019183416A1 (en) 2018-03-23 2019-09-26 Nevakar Inc. Epinephrine compositions and containers
KR102258546B1 (ko) 2018-10-26 2021-06-01 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US20070072817A1 (en) * 2005-09-29 2007-03-29 Fibrogen, Inc. Methods for reducing blood pressure
RU2011126338A (ru) * 2008-11-28 2013-01-10 Эбботт Лэборетриз Стабильные композиции антител и способы их стабилизации
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
PL2986308T3 (pl) * 2013-12-18 2020-05-18 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensyna ii w połączeniu do leczenia niedociśnienia

Also Published As

Publication number Publication date
CN106794224A (zh) 2017-05-31
CA2954016A1 (en) 2016-01-14
MX2017000306A (es) 2017-07-10
WO2016007589A1 (en) 2016-01-14
TW202214219A (zh) 2022-04-16
AU2021201669A1 (en) 2021-04-08
IL249936A0 (en) 2017-03-30
JP2017519799A (ja) 2017-07-20
EP3007722A1 (en) 2016-04-20
BR112017000303A2 (pt) 2017-11-07
AU2015287955A1 (en) 2017-02-02
JP2020143139A (ja) 2020-09-10
TW202038927A (zh) 2020-11-01
EP3007722A4 (en) 2016-05-25
TWI754225B (zh) 2022-02-01
TW201625231A (zh) 2016-07-16
EA202091873A3 (ru) 2021-01-29
US20160074465A1 (en) 2016-03-17
TWI688385B (zh) 2020-03-21
EA202091873A2 (ru) 2020-11-30
EP3381465A1 (en) 2018-10-03
EA036514B1 (ru) 2020-11-18
US20180311306A1 (en) 2018-11-01
KR20170026486A (ko) 2017-03-08
EA201692534A1 (ru) 2017-06-30
US20200237853A1 (en) 2020-07-30
SG11201610897VA (en) 2017-01-27

Similar Documents

Publication Publication Date Title
CY1123065T1 (el) Ανασυνδυασμενα προβιοτικα βακτηριδια
SG10201804034QA (en) Methods for treating hypotension
MX2017003797A (es) Macrociclos peptidomimeticos y usos de los mismos.
MD20160024A2 (ro) Modularea imunităţii tumorale
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
IL251028A0 (en) 17a,21-diesters of cortexolone for use in the treatment of tumors
PH12016502150A1 (en) Method for treating renal cell carcimona
MX377593B (es) Composiciones para usar en el tratamiento de cáncer renal.
EA201692284A1 (ru) Ниацинамид для стимуляции продуцирования антимикробных пептидов
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
MX2017006026A (es) Apilimod para uso en el tratamiento de cancer colorrectal.
NZ722600A (en) Methods of treating mild brain injury
TW201613587A (en) Medical treatments based on anamorelin
MX2018008299A (es) Metodos para administrar hepcidina.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2019004804A (es) Tratamiento para el prurigo nodula.
MX382608B (es) Tratamiento del prurito urémico.
GB2514940B (en) Process for the treatment of ash, treated ash thus obtained and uses of treated ash
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
EA201690914A1 (ru) Новое соединение для лечения тяжелой гипогликемии
EA201691036A1 (ru) Новое соединение для лечения тяжелой гипогликемии
MX362111B (es) Un metodo para mejorar la funcion hepatica.
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis